Pharmafile Logo

Research Partnership announces several new appointments

Research Partnership is delighted to welcome Anne Cunningham and Morten Andersen and announce that Sue Rees has joined our specialist Emerging Markets team.

Anne Cunningham has joined Research Partnership’s European division as a Director at the company’s global head office in London. Anne has over 25 years’ of practise in the pharmaceutical industry and brings with her extensive and wide ranging experience from roles in both client companies including AstraZeneca and on the agency side. Most recently Anne was Customer Insights Partner at AbbVie where she was responsible for leading an integrated programme of analytics, market research and insight generation to support AbbVie’s rheumatology brands. Prior to this she was Research Director at Cello Health Insight.

Morten Anderson has joined Research Partnership’s specialist quantitative team as an Associate Director. Morten joins us from Kantar Health, where he has spent the last 9 years, with a particular emphasis on large-scale quantitative and brand tracking projects for international clients.

Commenting on their appointments Mark Jeffery, Founding Director, said, “We are delighted to welcome both Anne and Morten to Research Partnership. Both bring with them a wealth of knowledge and expertise and we look forward to them contributing to the company’s ongoing growth and development as we celebrate our 20th anniversary. Having worked with Anne previously as a client of our syndicated market-tracking tool Therapy Watch, it’s great to now be able to welcome her to our ad-hoc team.”

Director Sue Rees, who first joined Research Partnership in 2013 in the company’s European division, has transitioned into the specialist Emerging Markets Division. Sue has over 25 years’ experience in market research from both agency and client-side.

Commenting on the move, Marc Yates, Director of Emerging Markets said “The Emerging Markets Division has continued to grow and in order to sustain this growth we needed to recruit a Director who could not only add to the skills of our existing team but hit the ground running. Sue’s knowledge and prior experience of working in the Asia market will be a strong asset to the team.”

Visit researchpartnership.com to find out more 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize...

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.